menu
    • menu

    Company profile for Eccogene

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. The company focuses on discovery and development of translational medicine in metabolic and immune-related diseases. Eccogene is specialized in disease biology, medicinal chemistry, and translational science to advance its novel and differentiated pipeline of drugs to addr...
    Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. The company focuses on discovery and development of translational medicine in metabolic and immune-related diseases. Eccogene is specialized in disease biology, medicinal chemistry, and translational science to advance its novel and differentiated pipeline of drugs to address the unmet medical needs for metabolic and immune-related diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EccogeneChina Flag
    Country
    Country
    China
    Address
    Address
    Room 402A, No. 326, Edison Road, Pudong New District, Shanghai, China
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.eccogene.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eccogene/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eccogene Posts Positive Ph 1b Data for Oral GLP-1 Elecoglipron
    Eccogene Posts Positive Ph 1b Data for Oral GLP-1 Elecoglipron

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210405505/en/Eccogene-Announces-Positive-Topline-Results-from-Phase-1b-Trial-of-Elecoglipron-AZD5004ECC5004-an-Oral-GLP-1-Receptor-Agonist-in-Adult-Participants-Living-with-ObesityOverweight-with-or-without-Type-2-Diabetes-in-China

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Eccogene Initiates MOSAIC Ph 2A Trial For MASH Treatment
    Eccogene Initiates MOSAIC Ph 2A Trial For MASH Treatment

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215323519/en/Eccogene-Announces-First-Patient-Enrolled-in-MOSAIC-Phase-2a-Trial-Evaluating-ECC4703-and-ECC0509-Individually-and-in-Combination-for-the-Treatment-of-MASH

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Eccogene Cleared By FDA For Phase 2a Trial On ECC4703 & ECC0509
    Eccogene Cleared By FDA For Phase 2a Trial On ECC4703 & ECC0509

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161592/0/en/Eccogene-Receives-U-S-FDA-Clearance-to-Initiate-Phase-2a-MOSAIC-Trial-of-ECC4703-and-ECC0509-for-MASH.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Eccogene Starts Phase 1b Trial of AZD5004/ECC5004 in China
    Eccogene Starts Phase 1b Trial of AZD5004/ECC5004 in China

    18 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/18/3101325/0/en/Eccogene-Announces-First-Patient-Dosed-in-Phase-1b-Trial-of-AZD5004-ECC5004-a-Novel-Oral-GLP-1-Receptor-Agonist-in-China.html

    GLOBENEWSWIRE
    18 Jun 2025
    Share Share
    Eccogene Shows ECC4703 Combos Spare Muscle, Burn Fat
    Eccogene Shows ECC4703 Combos Spare Muscle, Burn Fat

    17 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/17/3100531/0/en/Eccogene-to-Report-Preclinical-Data-with-ECC4703-Showcasing-Impact-on-Lean-Muscle-Sparing-and-Fat-Loss-in-Combination-with-Semaglutide-and-Tirzepatide.html

    GLOBENEWSWIRE
    17 Jun 2025
    Share Share
    Eccogene Appoints Dr. Jai Patel as Chief Medical Officer
    Eccogene Appoints Dr. Jai Patel as Chief Medical Officer

    01 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/01/3072242/0/en/Eccogene-Appoints-Dr-Jai-Patel-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    01 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search